324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
The Readout Loud
00:00
From Cake Celebrations to Major Pharmaceutical News
This chapter begins with a cheerful conversation about a cake made after apple picking, highlighting a team member's absence. The mood shifts as the discussion turns to the serious news of Pfizer withdrawing its sickle cell disease treatment and its potential impact.
Transcript
Play full episode
